Precision-Fermented Egg Protein Showcased in Onego Bio–Sigma Cooking Demonstration

According to a recent LinkedIn post from Onego Bio, the company is closing its webinar series on “The Power of Trichoderma reesei” with a live cooking demonstration featuring Bioalbumen, its non‑animal egg protein. The session, scheduled for May 12, 2026, is organized together with Sigma and focuses on showcasing practical food applications.

The post highlights that the webinar series has explored the efficiency of Trichoderma reesei and the role of precision fermentation in building a more resilient food system. In the final episode, Onego Bio’s Head of Product Development, Halle Redfearn, Ph.D., and Sigma’s Global R&D Manager, Andrea Nieto Gutiérrez, will demonstrate egg functionalities such as whipping and aeration in products like angel food cake, egg bites, and scrambled eggs.

For investors, the post suggests that Onego Bio is moving from technical discussion toward validating Bioalbumen’s performance in real-world use cases, which may be important for adoption by food manufacturers. The collaboration with Sigma could indicate interest from established industry players in precision-fermented egg alternatives, potentially supporting Onego Bio’s positioning in the emerging animal-free protein segment.

Demonstrating functional parity with conventional eggs across multiple formats may help address key commercialization hurdles such as texture and versatility, which are critical for broader market uptake. If the technology gains traction, this could expand Onego Bio’s addressable market in food ingredients and strengthen its competitive stance within the alternative protein and precision fermentation landscape.